http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105902515-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
filingDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105902515-B
titleOfInvention Nano medication memory, preparation method and its application
abstract The present invention relates to a kind of Nano medication memory, preparation method and its applications, the Nano medication memory is three block high-molecular copolymer composition, it is formed in water with drug effect self assembly, wherein the firstth segment of three block high-molecular copolymer is polylactic acid-glycolic acid 6000Da, second segment is Macrogol 3000 Da, and third segment is polymethyl benzene boric acid 15000Da.Using Nano medication memory, preparation method and its application in the invention, the raw material biocompatibility of use is fabulous, authenticated by U.S. FDA, it can self-degradation in vivo, it is widely used in food, drug, cosmetic field, can degrade the adult metabolite itself contained in vivo, exclude in vitro, to be perfectly safe and have no toxic side effect with body fluid.The applicable drug of this product is extensive, and module size and controlled shape, the medicament slow release time is controllable, and internal degradation speed is controllable.
priorityDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450733091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22062110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159482356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423239664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454536763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364031

Total number of triples: 37.